Kindly MD, Inc. (NAKA) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Kindly MD, Inc. stock (NAKA) is currently trading at $0.24. Kindly MD, Inc. PS ratio (Price-to-Sales) is 95.02. Analyst consensus price target for NAKA is $1.00. WallStSmart rates NAKA as Sell.
- NAKA PE ratio analysis and historical PE chart
- NAKA PS ratio (Price-to-Sales) history and trend
- NAKA intrinsic value — DCF, Graham Number, EPV models
- NAKA stock price prediction 2025 2026 2027 2028 2029 2030
- NAKA fair value vs current price
- NAKA insider transactions and insider buying
- Is NAKA undervalued or overvalued?
- Kindly MD, Inc. financial analysis — revenue, earnings, cash flow
- NAKA Piotroski F-Score and Altman Z-Score
- NAKA analyst price target and Smart Rating
Kindly MD, Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Kindly MD, Inc. (NAKA) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Kindly MD, Inc. (NAKA) Key Strengths (1)
Trading below book value, meaning the market prices it less than net assets
Supporting Valuation Data
Kindly MD, Inc. (NAKA) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Revenue declining -40.10%, a shrinking business
Very expensive at 95.0x annual revenue
Micro-cap company with very limited liquidity and high volatility
Low institutional interest, mostly retail-driven
Supporting Valuation Data
Kindly MD, Inc. (NAKA) Detailed Analysis Report
Overall Assessment
This company scores 20/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 1 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 1.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book. Valuation metrics including Price/Book (0.39) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (95.02) suggest expensive pricing. Growth concerns include Revenue Growth at -40.10%, which may limit upside. Profitability pressure is visible in Return on Equity at -37.60%, Operating Margin at -2680.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -37.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -40.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
NAKA Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
NAKA's Price-to-Sales ratio of 95.02x sits near its historical average of 103.66x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 15% below its historical high of 111.98x set in Mar 2026, and 0% above its historical low of 95.02x in Mar 2026.
WallStSmart Analysis Synopsis
Data-driven financial summary for Kindly MD, Inc. (NAKA) · FINANCIAL SERVICES › CAPITAL MARKETS
The Big Picture
Kindly MD, Inc. operates as a stable business with moderate growth and solid fundamentals. Revenue reached 2M with 40% decline year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Revenue contracted 40% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -13M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor CAPITAL MARKETS industry trends, competitive moves, and regulatory changes that could impact Kindly MD, Inc..
Bottom Line
Kindly MD, Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:24:08 AM
About Kindly MD, Inc.(NAKA)
NASDAQ
FINANCIAL SERVICES
CAPITAL MARKETS
USA
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company is headquartered in Salt Lake City, Utah.